Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARTL
DateTimeSourceHeadlineSymbolCompany
01/13/20258:00AMGlobeNewswire Inc.Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
12/09/20248:15AMGlobeNewswire Inc.Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related AnorexiaNASDAQ:ARTLArtelo Biosciences Inc
11/18/20247:30AMGlobeNewswire Inc.Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit NASDAQ:ARTLArtelo Biosciences Inc
11/13/20247:30AMGlobeNewswire Inc.Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration SymposiumNASDAQ:ARTLArtelo Biosciences Inc
11/12/20247:00AMGlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
11/08/20243:31PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARTLArtelo Biosciences Inc
11/08/20243:30PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ARTLArtelo Biosciences Inc
11/05/20247:30AMGlobeNewswire Inc.Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health’s “Preclinical Screening Platform for Pain” ProgramNASDAQ:ARTLArtelo Biosciences Inc
10/09/20248:00AMGlobeNewswire Inc.Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16thNASDAQ:ARTLArtelo Biosciences Inc
09/04/20248:00AMGlobeNewswire Inc.Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ARTLArtelo Biosciences Inc
08/13/20247:00AMGlobeNewswire Inc.Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
07/15/20247:30AMGlobeNewswire Inc.Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 InhibitorNASDAQ:ARTLArtelo Biosciences Inc
07/03/20248:00AMGlobeNewswire Inc.Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
07/02/20248:00AMGlobeNewswire Inc.Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor PlatformNASDAQ:ARTLArtelo Biosciences Inc
07/01/20248:00AMGlobeNewswire Inc.Artelo Biosciences Presents Preclinical Data on ART26.12 in Breast Cancer-Induced Bone Pain at the 34th Annual International Cannabinoid Research Society SymposiumNASDAQ:ARTLArtelo Biosciences Inc
06/04/20247:30AMGlobeNewswire Inc.Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain SocietyNASDAQ:ARTLArtelo Biosciences Inc
05/29/20247:30AMGlobeNewswire Inc.Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24NASDAQ:ARTLArtelo Biosciences Inc
05/13/20247:00AMGlobeNewswire Inc.Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
05/10/20248:00AMGlobeNewswire Inc.Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14thNASDAQ:ARTLArtelo Biosciences Inc
04/23/20247:30AMGlobeNewswire Inc.Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyNASDAQ:ARTLArtelo Biosciences Inc
04/22/20247:30AMGlobeNewswire Inc.Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeNASDAQ:ARTLArtelo Biosciences Inc
03/25/20247:00AMGlobeNewswire Inc.Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
03/12/20248:15AMGlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNASDAQ:ARTLArtelo Biosciences Inc
01/23/20247:30AMGlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyNASDAQ:ARTLArtelo Biosciences Inc
01/08/20247:30AMGlobeNewswire Inc.Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
12/05/20237:30AMGlobeNewswire Inc.Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
11/30/20238:00AMGlobeNewswire Inc.Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
11/13/20237:02AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
11/13/20237:00AMGlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
11/09/20238:00AMGlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNASDAQ:ARTLArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTL

Your Recent History

Delayed Upgrade Clock